CVS Health Corporation (CVS.DE) Stock Overview
Explore CVS Health Corporation’s financial performance, market position, analyst ratings, and future outlook.
CVS Health Corporation (CVS.DE)
Key Financials
Key Financials
Market Cap
100B
P/E Ratio
22.99
EPS (TTM)
$6.77
ROE
0.06%
CVS.DE Stock Analysis & Investment Overview (XETRA)
Our AI-powered analysis of CVS Health Corporation (XETRA: CVS.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CVS Health Corporation's XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CVS.DE on the XETRA shows an RSI of 48.12, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $84.13 for the XETRA listing.
Key metrics behind CVS Health Corporation's XETRA-traded stock include a P/E ratio of 22.99 and a market capitalization of 100B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CVS.DE on the XETRA.